NEPHROGENEX INC - COM (NRXGQ)

CUSIP: 640667101

Q1 2016 13F Holders as of 31 Mar 2016

Type / Class
Equity / COM
Total 13F shares
2,492,806
Share change
-565,100
Total reported value
$1,172,000
Price per share
$0.47
Number of holders
14
Value change
-$939,451
Number of buys
3
Number of sells
6

Quarterly Holders Quick Answers

What is CUSIP 640667101?
CUSIP 640667101 identifies NRXGQ - NEPHROGENEX INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NEPHROGENEX INC - COM (NRXGQ) as of Q1 2016

As of 31 Mar 2016, NEPHROGENEX INC - COM (NRXGQ) was held by 14 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,492,806 shares. The largest 10 holders included RHO CAPITAL PARTNERS INC, Visium Asset Management, LP, BVF INC/IL, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, CITADEL ADVISORS LLC, JPMORGAN CHASE & CO, KCG HOLDINGS, INC., GOLDMAN SACHS GROUP INC, and BlackRock Fund Advisors. This page lists 14 institutional shareholders reporting positions in this security for the Q1 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.